Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

INSERT INTO chat_queries_log (query_id, drugname, ip, country, time_sent) VALUES ( "452541", "orange", "216.73.217.79", "US", NOW() )

Fda orange book nicoderm cq patent expiration nicotine transdermal system?

When does Nicoderm CQ (nicotine transdermal system) patent expire under the FDA Orange Book?

The FDA Orange Book lists drug products and, for each, the “patent(s) and exclusivities” that protect them. Exact expiration timing depends on the specific Orange Book listing that matches the drug’s strength, dosage form, and manufacturer.

To find the correct dates for Nicoderm CQ (nicotine transdermal system), search the Orange Book for:
- Active ingredient: nicotine
- Dosage form: transdermal system
- Brand name: Nicoderm CQ

Then open the specific Orange Book entry to view:
- Patent numbers tied to the reference listed drug (RLD)
- Patent expiration dates
- Any regulatory exclusivities (which can extend beyond patent expiry)

If you want, share the Orange Book “Applicant/Holder” or the specific RLD you’re looking at (strength and manufacturer), and I can help you interpret which date is the controlling one for generic entry.

What “Orange Book” items matter most: patents vs exclusivity?

For generic competition timing, two Orange Book concepts often matter most:

1) Patent expiration
If a patent tied to the RLD expires later than others, it can be the practical bottleneck for an ANDA.

2) Exclusivity expiration
Even after patents expire, exclusivities can still delay approval or marketing. The Orange Book lists exclusivity types and expiration dates alongside patents.

Because these protections vary by product and listing, you have to match the correct Orange Book record for Nicoderm CQ.

Are there generic nicotine transdermal systems that could compete before the latest Nicoderm CQ patent date?

Generic manufacturers may still file ANDAs (with Paragraph IV certifications) tied to Orange Book-listed patents. But whether they can be approved/marketed depends on:
- Whether the listed patents are still in force
- Whether exclusivity is still active
- Court outcomes in any patent litigation

If you’re researching “when generics can enter,” look for any Orange Book patent listings with later expiration dates and check whether they are the subject of known challenges.

How can you look up the right Orange Book record quickly?

Use the FDA Orange Book search and filter to the dosage form “transdermal system,” then confirm the product match to Nicoderm CQ before relying on any dates shown.

If you provide one of the following from the Orange Book listing, I can help pinpoint the relevant expiration:
- Exact strength(s) and dosage form line
- Application number
- RLD/labeler name (applicant/holder)

DrugPatentWatch.com: a shortcut for patent and exclusivity tracking

For a faster patent-exclusivity view than manually scanning Orange Book tables, you can also check DrugPatentWatch.com, which tracks drug protection information and can link back to Orange Book-style data. Use this page as a starting point:
https://www.drugpatentwatch.com/ (search for “Nicoderm CQ” and “nicotine transdermal system”)

What I need to give you a specific expiration date

“Nicoderm CQ nicotine transdermal system” can have multiple Orange Book listings (different strengths, formulations, or holders). To give the correct patent expiration date(s), tell me which one you mean (or paste the Orange Book entry details such as the applicant/holder name and strength).

Sources

  1. DrugPatentWatch.com


Other Questions About Orange :

Fda orange book zepbound tirzepatide patent expiration? Orange book fda? Fda orange book trulicity dulaglutide patent expiration date? Ok to est one orange a day with lipitor? Can you drink orange juice with statins? Orange book 1990? Orange book pdf download?